Description
This product utilizes CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone I1CSS22-22). We employs the Retrovirus (T7-mNeonGreen-IL-4-KpnI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
CD22
Clone
I1CSS22-22
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mNeonGreen
Promoter
T7
Effector Gene
IL-4
Insertion Sites
KpnI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
Retrovirus
Transformation Accuracy
0.89
Cell Culture
Aseptic Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.